Literature DB >> 11004281

Amniotic membrane transplantation in acute chemical and thermal injury.

M S Sridhar1, A K Bansal, V S Sangwan, G N Rao.   

Abstract

PURPOSE: To present a case of chemical injury and a case of thermal injury treated by amniotic membrane transplantation in acute phase.
METHODS: Case reports. An eye with sodium hydroxide injury, opaque cornea, and limbal ischemia of more than 180 degrees and an eye with hot tea injury, opaque cornea, stromal edema, and scarring were treated by amniotic membrane transplantation within the first few weeks of injury.
RESULTS: In the eye with sodium hydroxide injury, 4 months after amniotic membrane transplantation, the ocular surface is stable, superficial corneal scarring with vascularization is present, and visual acuity is 20/25. In the eye with thermal injury, 6 months after amniotic membrane transplantation, the ocular surface is stable, but there is superficial scarring and vascularization, and visual acuity is 20/20.
CONCLUSIONS: Amniotic membrane transplantation can be considered in chemical injury with severe limbal ischemia and in severe thermal injury in acute phase. Long-term studies are warranted to evaluate further the efficacy of amniotic membrane transplantation in these clinical situations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004281     DOI: 10.1016/s0002-9394(00)00500-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  18 in total

1.  A new classification of ocular surface burns.

Authors:  H S Dua; A J King; A Joseph
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

2.  TRPA1 is required for TGF-β signaling and its loss blocks inflammatory fibrosis in mouse corneal stroma.

Authors:  Yuka Okada; Kumi Shirai; Peter S Reinach; Ai Kitano-Izutani; Masayasu Miyajima; Kathleen C Flanders; James V Jester; Makoto Tominaga; Shizuya Saika
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

Review 3.  Concise review: the coming of age of stem cell treatment for corneal surface damage.

Authors:  Charanya Ramachandran; Sayan Basu; Virender S Sangwan; Dorairajan Balasubramanian
Journal:  Stem Cells Transl Med       Date:  2014-09-09       Impact factor: 6.940

4.  TRPV1 involvement in inflammatory tissue fibrosis in mice.

Authors:  Yuka Okada; Peter S Reinach; Kumi Shirai; Ai Kitano; Winston W-Y Kao; Kathleen C Flanders; Masayasu Miyajima; Hongshan Liu; Jianhua Zhang; Shizuya Saika
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

Review 5.  Corneal stem cells and tissue engineering: Current advances and future perspectives.

Authors:  Aline Lütz de Araujo; José Álvaro Pereira Gomes
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

6.  Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice.

Authors:  Shizuya Saika; Takeshi Miyamoto; Osamu Yamanaka; Tadashi Kato; Yoshitaka Ohnishi; Kathleen C Flanders; Kazuo Ikeda; Yuji Nakajima; Winston W-Y Kao; Misako Sato; Yasuteru Muragaki; Akira Ooshima
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

7.  Temporary sutureless amniotic membrane patch for acute alkaline burns.

Authors:  Ahmad Kheirkhah; Daniel A Johnson; Deval R Paranjpe; V K Raju; Victoria Casas; Scheffer C G Tseng
Journal:  Arch Ophthalmol       Date:  2008-08

8.  Minimal conjunctival limbal autograft for total limbal stem cell deficiency.

Authors:  Ahmad Kheirkhah; Vadrevu K Raju; Scheffer C G Tseng
Journal:  Cornea       Date:  2008-07       Impact factor: 2.651

Review 9.  Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Elizabeth Shay; Ahmad Kheirkhah; Lingyi Liang; Hossam Sheha; Darren G Gregory; Scheffer C G Tseng
Journal:  Surv Ophthalmol       Date:  2009-08-21       Impact factor: 6.048

Review 10.  Limbal stem cell transplantation: new progresses and challenges.

Authors:  L Liang; H Sheha; J Li; S C G Tseng
Journal:  Eye (Lond)       Date:  2008-12-19       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.